INTRODUCTION
Since its first description, mastopexy with prosthesis continues to be a challenge
for all plastic surgeons since its first description1,2. Consistent long-term results are still difficult to obtain for many reasons, and
some authors advocate caution due to complications3,4.
One of the most common reasons for surgical revision is ptosis recurrence, which can
have many underlying factors, but the lack of reliable long-term support is the main
cause5. The pectoralis major muscle has been studied and used in many techniques with different
results6-15, although pure dual-plane is still preferred in most studies16-21. Daniel developed a technique in 2005 that he called “double space,” in which he
divides the pectoralis major muscle inferolateral to create a pocket where the implant
will be placed8.
The lead author of this study has been using this technique since 2012 and describes
his experience in 92 consecutive cases (184 breasts) with two modifications for better
pocket stability and consistency of results15,19,22,23.
OBJECTIVES
This study aims to describe a single surgeon’s experience in a modified approach to
augmentation mastopexy.
METHODS
This study was conducted following the 1964 Declaration of Helsinki guidelines and
later amendments or comparable ethical standards. The patients came from the surgeon’s
private clinic who authored the study.
This retrospective study included 92 consecutive cases (184 breasts) of single-stage
augmentation mastopexy performed at Hospital Pietá, in Curitiba, PR, by the same surgeon
using a modified double space technique between March 2012 and October 2019
Weight and body mass index (BMI) were checked before surgery; smokers were encouraged
to quit 30 days earlier. Those who did not comply with the request were denied surgery.
Preoperative and postoperative photographs were taken.
All patients received perioperative antibiotics and the application of intermittent
lower limb compression devices. Epidural anesthesia associated with sedation was used.
No drain was placed in any case. Each patient was discharged on the day of surgery
(except when associated surgeries were performed) and encouraged to ambulate soon
after sedation wore off. Analgesics and anti-inflammatories were maintained for an
average of one week. The surgical bra was indicated for 2 months.
Patients were followed up at 1 day, 1-2 weeks, 1-2-3-6 months, and annually.
Complications were defined as “tissue-related” and “implant-related.” Revisions were
defined as minor (performed under local or local anesthesia/sedation for less than
30 minutes) and major (lasting longer than 30 minutes under epidural/sedation). No
patient satisfaction assessment was made.
Statistical analysis of the data was performed using chi-square (χ2) analysis and
Spearman’s correlation test. Spearman’s correlation test compared revision rates and
possible risk factors (smoking, BMI, previous breast surgery, bariatric surgery, and
breastfeeding). Statistical significance was defined as p< .05.
Inclusion criteria
Pseudoptosis, grade I or higher breast ptosis (Regnault classification) and hypoplasia.
Exclusion criteria
Significant asymmetry requiring augmentation only on one side and mastopexy on the
other. Active smokers.
Surgical description of the double space technique
Patients underwent mastopexy with an inverted or vertical T scar. The implant was
accessed through the vertical incision until the pectoralis major fascia was found,
then a subfascial pocket was created at the superior and medial pole according to
the size of the implant, and breast tissue reduction was performed when necessary.
The double space technique was the same as in the cases described by Daniel in 2005.
The pectoralis major muscle was divided along the same axis of its fibers 3 cm above
its lower border (on average) to the axillary fibers and connected to the adjacent
breast tissue. The sternum inserts were sectioned to create an inferolateral submuscular
pocket where the implant would be inserted. The size of the pocket varied according
to the size of the implant, intending to cover at least 30-40% of the implant, which
also facilitated the fixation of the muscle flap to the medial pillar of the breast
(Figure 1).
Figure 1 - Graphical representation of the modified double space technique.
Figure 1 - Graphical representation of the modified double space technique.
One of the modifications made by the author was the use of a subfascial plane in the
superomedial pole, while Daniel used a subglandular approach23.
Muscle flap fixation
The other modification was the fixation of the muscle flap to the medial pillar of
the breast tissue to stabilize the pocket using nylon 2.0 in separate “U” sutures
(at least 4). An extra locking suture was performed last year to reinforce the suture
line and prevent muscle tearing.
Mastopexy
The implant plane was subfascial at the superomedial pole and submuscular at the inferolateral
pole. Then, approximation of the breast pillars using 2.0 nylon so that the implant
was covered by two layers: muscle flap and mastopexy breast parenchyma. Subcutaneous
cellular tissue and skin were closed in layers with monocryl 3.0 and 4.0, surgical
glue (Dermabond®) was used. The nipple was exposed with the open technique. The drain
was not used in any case.
Secondary cases
The muscle flap had to be made differently in patients with previous breast augmentation
surgery. If the anterior plane was subglandular or subfascial, the muscle flap was
created and left separate from the glandular tissue. If the anterior plane was submuscular,
most patients had significant retraction of the pectoralis major muscle, so the flap
was also created with a portion of the inferolateral capsule (Figure 2).
Figure 2 - Secondary cases. Mixed flap of muscle and capsule.Mixed flap in secondary cases. A:
Showing implant in the submuscular position and the opening to be made in the blue
line to have a mixed flap: pectoralis major muscle (blue arrow) and implant capsule
(yellow arrow). B: Double space technique with already performed mixed flap fixation
and secure and stabilized implant (suture line on the side of the green line).
Figure 2 - Secondary cases. Mixed flap of muscle and capsule.Mixed flap in secondary cases. A:
Showing implant in the submuscular position and the opening to be made in the blue
line to have a mixed flap: pectoralis major muscle (blue arrow) and implant capsule
(yellow arrow). B: Double space technique with already performed mixed flap fixation
and secure and stabilized implant (suture line on the side of the green line).
RESULTS
The age of the patients ranged from 17 to 54 years, with a mean of 41.67 years. The
mean BMI was 24.2. The implant size ranged from 150 ml to 450 ml (average 281 ml),
all high-profile or ultra-high profile textured rounds. The mean follow-up was 14
months (Table 1).
Table 1 - Patient demographics.
|
Augmentation mastopexy (92 patients) |
Age (years) |
17-54 (41.61) |
Follow-up (months) |
6-72 (14) |
BMI |
24.22 (média) |
Smokers |
6 (6.52%) |
Previous breast surgery |
39 (42.39%) |
Post-bariatric |
5 (5.44%) |
Breast-feeding |
49 (53.26%) |
Table 1 - Patient demographics.
Five patients (5.4%) were post-bariatric, and 49 patients (53.3%) had a history of
breastfeeding. Only six patients (6.5%) were smokers, and 39 patients (42.4%) had
previous breast surgery (augmentation, augmentation, mastopexy or reduction mammoplasty).
All patients underwent a double space approach for internal implant support, and most
cases were performed with inverted T mastopexy (90.25%) and some (9.75%) with only
a vertical and periareolar scar.
The complication rate was 27.17%. There were no cases of postoperative infection or
necrosis of flaps or nipple-areolar complex (NAC). Only one patient (1.09%) had NAC
suffering in a secondary mastopexy, which was completely resolved with cilostazol
100 mg/day for 10 days associated with three hyperbaric chamber sessions.
There were more tissue-related complications than implant-related complications (Table 2). Three patients (3.26%) had grade III capsular contracture: one underwent capsulectomy
with replacement of implants, the second underwent explantation with capsulectomy
and new mastopexy, the third was treated only with Singulair 10 mg/day for 3 months,
with improvement to a grade I contracture and no reoperation was necessary.
Table 2 - Complications related to the implant and tissues.
|
Total |
% |
Conduct |
Implant |
|
|
|
Capsular contracture |
3 |
3.26 |
Capsulectomy and implant replacement/Explant/Singulair 10 mg/day |
Asymmetry |
1 |
1.09 |
Lipoinjection/scar revision |
Tissue |
|
|
|
Recurrent ptosis |
7 |
7.61 |
New mastopexy |
Unsightly scars |
6 |
6.52 |
Scar review |
Dynamic deformity |
4 |
4.35 |
Lipoinjection |
Loss of muscle strap attachment |
3 |
3.26 |
New fixation with locking suture |
NAC suffering |
1 |
1.09 |
Hyperbaric chamber and cilostazol 100 mg/day |
Table 2 - Complications related to the implant and tissues.
The most common complication was recurrent ptosis (7.61%), and all patients underwent
a new mastopexy for correction. Unaesthetic scars were the second most common complication
(6.52%), and some patients were reviewed with only local anesthesia, but the epidural
was used when another complication was treated in the same patient. It was found in
three patients (3.26%) the rupture of fixation of the muscle flap and loss of support
for this reason; all were surgically revised for new fixation with locking suture.
In four patients (4.35%), lipoinjection was necessary for the inferolateral quadrant
due to the dynamic deformity of the muscular loop (Figure 3).
Figure 3 - Dynamic deformity. A 51-year-old woman with a periareolar mastopexy performed 11 years
earlier with a 280 ml high-profile prosthesis. She wanted to restore the shape and
volume of the breasts and also to repair scars. The patient underwent augmentation
mastopexy with a vertical scar and placement of a 335 ml high-profile implant using
the double space technique. She had visible dynamic deformity at the lower pole and
underwent revision with 150 ml lipoinjection and also changed to an inverted T scar.
The oblique view is shown at 6 months postoperatively with dynamic deformity in the
lower pole (left, green arrow) and 1 year after revision (right).
Figure 3 - Dynamic deformity. A 51-year-old woman with a periareolar mastopexy performed 11 years
earlier with a 280 ml high-profile prosthesis. She wanted to restore the shape and
volume of the breasts and also to repair scars. The patient underwent augmentation
mastopexy with a vertical scar and placement of a 335 ml high-profile implant using
the double space technique. She had visible dynamic deformity at the lower pole and
underwent revision with 150 ml lipoinjection and also changed to an inverted T scar.
The oblique view is shown at 6 months postoperatively with dynamic deformity in the
lower pole (left, green arrow) and 1 year after revision (right).
The revision rate was 25.3% (Table 3), and two (8.7%) of these were considered minor because they were performed under
sedation/local or local only lasted less than 30 minutes. Revisions performed under
sedation/epidural were considered major, took more than 30 minutes, and were performed
in deeper structures (breast tissue, muscle). Four patients (4.4%) had two associated
complications (Table 3). Long-term results are shown in primary (Figure 4), secondary (Figure 5) and post-bariatric (Figure 6) patients.
Table 3 - Complications and reviews.
|
Augmentation mastopexy (92 patients) |
% |
Revision |
Recurrent ptosis |
7 |
7.61 |
7 |
Capsular contracture |
3 |
3.26 |
2 |
Unsightly scars |
6 |
6.52 |
6 |
Dynamic deformity |
4 |
4.35 |
4 |
Asymmetry |
1 |
1.09 |
1 |
Loss of muscle strap attachment |
3 |
3.26 |
3 |
NAC suffering |
1 |
1.09 |
0 |
Size (very large) |
0 |
0.00 |
0 |
Table 3 - Complications and reviews.
Figure 4 - Primary case.A 43-year-old patient with grade 2 postpartum ptosis, desiring restoration
of breast volume and projection. The patient underwent an inverted T-augmentation
mastopexy and placement of an ultra-high-profile 285 ml double spaced implant. The
anterior view is shown preoperatively (left) and 3 years postoperatively (right).
Figure 4 - Primary case.A 43-year-old patient with grade 2 postpartum ptosis, desiring restoration
of breast volume and projection. The patient underwent an inverted T-augmentation
mastopexy and placement of an ultra-high-profile 285 ml double spaced implant. The
anterior view is shown preoperatively (left) and 3 years postoperatively (right).
Figure 5 - Secondary case. Prior dual-plane.A 48-year-old patient with an augmentation mastopexy
performed 7 years earlier with a 300 ml high-profile implant. She wanted restoration
of the shape and volume of her breasts. She underwent an inverted T-augmentation mastopexy
with resection of 405 g of breast tissue and placement of an ultra-high-profile 375
ml implant and switch from dual plane to dual space technique. The anterior view is
shown preoperatively (left) and 4 years postoperatively (right).
Figure 5 - Secondary case. Prior dual-plane.A 48-year-old patient with an augmentation mastopexy
performed 7 years earlier with a 300 ml high-profile implant. She wanted restoration
of the shape and volume of her breasts. She underwent an inverted T-augmentation mastopexy
with resection of 405 g of breast tissue and placement of an ultra-high-profile 375
ml implant and switch from dual plane to dual space technique. The anterior view is
shown preoperatively (left) and 4 years postoperatively (right).
Figure 6 - Post-bariatric patient.A 40-year-old patient with grade 2 ptosis after bariatric surgery,
desiring volume restoration and breast projection. She underwent an inverted T-augmentation
mastopexy and implant placement in a 310 ml double space ultra-high profile. The anterior
and oblique views are shown preoperatively (left), 1 year postoperatively (center),
and 6 years postoperatively (right).
Figure 6 - Post-bariatric patient.A 40-year-old patient with grade 2 ptosis after bariatric surgery,
desiring volume restoration and breast projection. She underwent an inverted T-augmentation
mastopexy and implant placement in a 310 ml double space ultra-high profile. The anterior
and oblique views are shown preoperatively (left), 1 year postoperatively (center),
and 6 years postoperatively (right).
We found no statistically significant difference in revision rates in risk factors
such as smoking, previous breast surgery, post-bariatric patients and breastfeeding
history (Figure 7).
Figure 7 - Risk factors for surgical revision.
Figure 7 - Risk factors for surgical revision.
DISCUSSION
Daniel first described the double space technique in 2005 in a series of 320 patients
in which he used it for primary and secondary cases for breast augmentation and augmentation
mastopexy. Daniel claimed that his technique combined the advantages of the submuscular
plane (better coverage at the lower pole, more support, less rippling) and subglandular
(faster recovery, no dynamic deformities, no implant displacement or waterfall deformity).
Furthermore, according to him, the disadvantages of each were eliminated8.
One of the problems in breast surgery studies is the variety of surgical techniques
and maneuvers to treat muscle, breast tissue and skin, not to mention the implant
itself (size, profile, filling, texturing)5,16,24-26. Therefore, these factors can influence the result and the revision/complication
rates17,27,28.
There is also the patient perspective, of course, which can increase the demand for
surgical revisions even when the result is more than satisfactory in the eyes of the
surgeon. Another aspect to consider is the cultural differences between countries,
when accepting certain results may be lower. In Brazil, women are much more demanding,
especially regarding filling the upper pole and firmness of the breasts, even with
a previous history of great weight loss and breastfeeding. Therefore, requests for
revisions to achieve these goals are quite common in our environment17,25,26 (Figure 8).
Figure 8 - Pseudoptosis.A 35-year-old patient presenting with pseudoptosis, desiring breast volume
and projection. The patient underwent an inverted T augmentation mastopexy with resection
of 58 g of breast tissue and placement of a prosthesis in a 250 ml high-profile double
space. After 6 months, she still wanted more projection and filling of the upper pole,
with a more marked and artificial appearance. She underwent revision with an ultra-high
295 ml double spaced implant and new mastopexy. The anterior view is shown preoperatively
(left), 6 months postoperatively (center), and 12 months after revision (right).
Figure 8 - Pseudoptosis.A 35-year-old patient presenting with pseudoptosis, desiring breast volume
and projection. The patient underwent an inverted T augmentation mastopexy with resection
of 58 g of breast tissue and placement of a prosthesis in a 250 ml high-profile double
space. After 6 months, she still wanted more projection and filling of the upper pole,
with a more marked and artificial appearance. She underwent revision with an ultra-high
295 ml double spaced implant and new mastopexy. The anterior view is shown preoperatively
(left), 6 months postoperatively (center), and 12 months after revision (right).
One of the only systematic reviews evaluating single-step augmentation mastopexy found
significant inter-study heterogeneity in complications and reviews25. The most common individual complication was recurrent ptosis, with a pooled rate
of 5.2%, as in other studies9,18,20. In the present study (7.61%), it was also the most common complication. Therefore,
all efforts to avoid this complication should be made. Many authors have published
different forms of implant support11-13,15,26,29,30.
In 2018, an author made a similar approach, but with a different muscle flap fixation
and only in secondary cases, and did not mention the work of Daniel (2005), although
the muscle flap was the same15. The fixation used in the current study is with at least 4 stitches on the medial
pillar with a locking suture to prevent the muscle flap from being torn by the suture
line. More sutures can help prevent muscle tears found in three patients, even with
4 or more sutures. In the last year, a blocking suture was added in an attempt to
solve this problem, and so far, this complication has not been observed anymore.
Munhoz (2019) published a study with a very similar technique called CRIMS (composite
reverse inferior muscle sling), but there was no report of dynamic deformity or recurrent
ptosis in this study. This is probably due to a small sample (32 patients), in which
only primary cases were operated. The size of the pocket that this author created
for implant insertion varied according to the size of the implant, covering at least
50-60% of the implant. A similar approach was used regarding pocket size, but as the
mean size was larger (281 ml compared to 255 ml), the desired coverage was 30-40%
of the implant11.
Daniel claimed that there was no dynamic deformity with this technique, but the author
found it in 4.35% of the patients (4 cases) in the lower pole, and these patients
had to undergo lipoinjection for correction. It is possible that this complication
is related to incomplete detachment of the pocket and also to the position of the
pectoralis major muscle and its relationship with the inframammary fold (IMF), as
claimed by Maclin et al. (2015)31. The authors state that the lateral extension of the IMF can be difficult to identify
and varies according to the size of the breast and the size of the patient.
On average, the IMF is 2 cm lower than the lower limit of the pectoralis major muscle,
and the lower muscular origin can be found in the 5th, 6th or 7th rib32. Sometimes, especially in larger implants, the detachment must include serratus muscle.
It was also observed in this series that, on the left side, the insertion of the pectoralis
major muscle is generally more cranial than on the right side. Since the technique
presented in this study is based on the support of a pectoralis major flap inferolateral,
the muscle fibers are not divided as in the dual plane technique. This is the main
reason why authors using dual planes would not have this complication in the inferolateral
pole because muscle contraction acts differently from the current technique3,5,16,17,20,21.
No cases of waterfall deformity (Waterfall/Snoopy nose) were found when the implant
is in the right position and the breast parenchyma “falls” or slides over it15,22. This appears more in a long-term evaluation, irrespective of implant texture and
insertion plane. The technique creates two different implant contact surfaces, a subfascial
(superomedial half) and a submuscular (inferolateral half), which could reduce this
complication’s chances. In addition, the modification applied by the author can help
avoid this deformity since there is a fixation between muscle and breast tissue. Other
studies may consider waterfall deformity as pseudoptosis or recurrent ptosis, but
they are different entities4.
There was no skin flap or NAC necrosis in this case series, only one case of NAC suffering
resolved with hyperbaric chamber sessions and cilostazol. Although almost 40% of the
patients had previous breast surgeries, these patients are notoriously more likely
to have blood flow compromised with tissue atrophy4. This demonstrates the safety of the technique concerning the blood supply of the
flaps.
Scarring is one of the most common complications of any mammoplasty, whether reduction
or mastopexy. When breast augmentation tension is applied to the same procedure as
augmentation mastopexy, small dehiscence and enlarged scars are more likely to occur.
This was the second most common cause of complication (6.52%). Some revisions were
minor and performed under local anesthesia (small areas), but others required an epidural,
especially when associated with longer scarring or other problems (recurrent ptosis,
dynamic deformities, or other areas). Other authors also found this, and some had
higher rates, probably due to the use of implants larger than the average of this
series (281 ml)6,9,10,11,14-17,20,21,29,33,34.
Recurrent ptosis is the reason why there are so many different techniques for sagging
breasts. When augmentation is added to mastopexy, extra elements are added to the
equation: implant size and texture, position (under or above the muscle), the interconnection
between the implant and breast tissue (waterfall deformity), amount of residual breast
tissue. The mastopexy technique is also important for long-term results. What is the
real cause of recurrent ptosis? Implant, mastopexy or both25?
The rate of recurrent ptosis found was similar to some studies9,15,29,30,34, but significantly higher than others10,17,18,20,21,33,35,36. Again, other studies with similar approaches had lower rates of recurrent ptosis,
probably because they were small series of patients, short follow-up or only primary
cases11,15. The muscle flap remains active even after many years of the postoperative period,
demonstrating that the technique provides adequate support without relying solely
on mastopexy.
Although 42.4% of the cases in this series had previous breast surgeries, 5.44% were
post-bariatric and more than half (53.26%) of patients had a history of breastfeeding;
there was no statistically significant difference between these variables in the rate
of complications/revisions. The rate of smokers (6.52%) was small and did not influence
this rate of complications and revisions. Most studies do not assess these factors
as determinants of outcomes, complications, and reviews. Calobrace et al. (2013)17, on the other hand, evaluated this variable and found a higher complication rate
in secondary than in primary cases.
The complication rate was 27.5%, similar to some studies16,17,20,21,29,35, but higher than others11,15,18. These last studies were of a small series of cases (around 30) or had a short follow-up13, which could explain the lower rate of complications. Two studies had very high complication
rates (about 50%)9,36, perhaps because both authors considered minor changes as complications: minor hematomas,
superficial skin vesicles, minor dehiscence, discrete skin remnants (ears) even areolar
overgrowth. Most studies did not consider these factors as complications.
The overall review rate was 25.5%, similar to that of Calobrace et al. (2013)17 and Hubbard (2019)37, but higher than that of other authors15,18,33,35. This finding has many nuances: short follow-up, small series, and only primary cases
are just some of them. Cultural differences in the acceptance of results can also
be brought to light, which means that some patients go for a review with very good
results already effectively26. For example, Spear et al.18 had 54% of patients who completed a satisfaction survey saying that they would want
revision surgery, but their revision rate was only 14%.
Calobrace et al.17 found approximately 30% of revision surgery in secondary cases, 10% more than in
primary cases. As almost 40% of the surgeries in this series were secondary, a higher
revision rate would be expected considering the difficulty of these cases (change
of planes, poorly placed scars, devascularized tissues, parenchymal atrophy and capsular
contracture4. However, no statistical difference was found significant in secondary cases.
Study limitations
It is a retrospective study; no satisfaction rating was made. The technique has evolved
over the years to make the pocket and fix the muscle flap to improve results. The
author first performed the double-space technique in 2012; these patients include
their learning curve. There are no objective measures to assess pre/post-operative
or short/long-term outcomes.
This study tolerates relatively short follow-up times to maximize the enrollment rate.
CONCLUSION
The modified double-space technique in our experience shows consistent long-term results,
and revision/complication rates were similar to some studies but higher than others.
Prior breast surgery, smoking, breastfeeding, and previous bariatric surgery do not
increase rates of complications and revisions.
It can be one of the options for covering and supporting implants in augmentation
mastopexy procedures.
REFERENCES
1. Gonzalez-Ulloa M. Correction of hypotrophy of the breast by exogenous material. Plast
Reconstr Surg Transplant Bull. 1960;25:15-26.
2. Regnault P. The hypoplastic and ptotic breast: a combined operation with prosthetic
augmentation. Plast Reconstr Surg. 1966;37(1):31-7.
3. Spear S. Augmentation/Mastopexy: “Surgeon Beware”. Plast Reconstr Surg. 2003;112(3):905-6.
4. Handel N. Secondary mastopexy on the augmented patient: a recipe for disaster. Plast
Reconstr Surg. 2006;118(7 Suppl):152S-63S.
5. Spear SL, Dayan JH, Clemens MW. Augmentation mastopexy. Clin Plast Surg. 2009;36(1):105-15.
6. Auersvald A, Auersvald LA. Mastopexy and breast augmentation using a pectoral muscle
loop. Aesthetic Plast Surg. 2011;35(3):333-40.
7. Borovlkov A. Use of myofascial flaps in aesthetic breast surgery. Aesthet Surg J.
2004;24(4):331-41.
8. Daniel MJB. Inclusão de Prótese de Mama em Duplo Espaço - Prêmio Georges Arié 2004.
Rev Bras Cir Plást. 2005;20(2):82-7.
9. Karacaoglu E. Single stage augmentation mastopexy: a novel technique using autologous
dermal graft. Ann Plast Surg. 2009;63(6):600-4.
10. Khan UD. Augmentation mastopexy in muscle-splitting biplane: an outcome of first 44
consecutive cases of mastopexies in a new pocket. Aesthetic Plast Surg. 2010;34(3):313-21.
11. Munhoz AM, Marques Neto A, Ferrari O. Single-Stage Augmentation Mastopexy With Composite
Reverse Inferior Muscle Sling Technique for Autologous Reinforcement of the Inferior
Pole: Technical Refinements and Outcomes. Aesthet Surg J. 2020;40(6):NP356-73.
12. Ono MT, Kerner BM. Four-step augmentation mastopexy: Lift and augmentation at single
time (LAST). Plast Reconstr Surg Glob Open. 2019;7(11):e2523.
13. Procópio LD, Silva DDP, Rosique R. Implante submuscular em duplo bolso para mastopexias
de aumento. Rev Bras Cir Plást. 2019;34(2):187-95.
14. Steinbacher DM, Singh N, Katz R, Khalifeh M. Augmentation- mastopexy using an autologous
parenchymal sling. Aesthetic Plast Surg. 2010;34(5):664-71.
15. Valente DS. Reverse-Muscle Sling Reduces Complications in Revisional Mastopexy-Augmentation.
Aesthetic Plast Surg. 2018;42(5):1202-12.
16. Beale EW, Ramanadham S, Harrison B, Rasko Y, Armijo B, Rohrich RJ. Achieving predictability
in augmentation mastopexy. Plast Reconstr Surg. 2014;133(3):284e-92e.
17. Calobrace MB, Herdt DR, Cothron KJ. Simultaneous augmentation/mastopexy: a retrospective
5-year review of 332 consecutive cases. Plast Reconstr Surg. 2013;131(1):145-56.
18. Spear SL, Pelletiere CV, Menon N. One-stage augmentation combined with mastopexy:
aesthetic results and patient satisfaction. Aesthetic Plast Surg. 2004;28(5):259-67.
19. Spring MA, Hartmann EC, Stevens WG. Strategies and Challenges in Simultaneous Augmentation
Mastopexy. Clin Plast Surg. 2015;42(4):505-18.
20. Stevens WG, Stoker DA, Freeman ME, Quardt SM, Hirsch EM, Cohen R. Is one-stage breast
augmentation with mastopexy safe and effective? A review of 186 primary cases. Aesthet
Surg J. 2006;26(6):674-81.
21. Stevens WG, Macias LH, Spring M, Stoker DA, Chacón CO, Eberlin SA. One-Stage Augmentation
Mastopexy: A Review of 1192 Simultaneous Breast Augmentation and Mastopexy Procedures
in 615 Consecutive Patients. Aesthet Surg J. 2014;34(5):723-32.
22. Frame J. The waterfall effect in breast augmentation. Gland Surg. 2017;6(2):193-202.
23. Graf R, Bernardes A, Rippel R, Araujo LR, Damasio R, Auersvald A. Subfascial breast
implant: a new procedure. Plast Reconstr Surg. 2003;111(2):904-8.
24. Karnes J, Morrison W, Salisbury M, Schaeferle M, Beckham P, Ersek RA. Simultaneous
breast augmentation and lift. Aesthetic Plast Surg. 2000;24(2):148-54.
25. Kavanin N, Jordan SW, Rambachan A, Kim JYS. A systematic review of single-stage augmentation-mastopexy.
Plast Reconstr Surg. 2014;134(5):922-31.
26. Sarosiek K, Maxwell PG, Unger JG. Getting the Most Out of Augmentation-Mastopexy.
Plast Reconstr Surg. 2018;142(5):742e-59e.
27. Spear SL, Low M, Ducic I. Revision augmentation mastopexy: indications, operations,
and outcomes. Ann Plast Surg. 2003;51(6):540-6.
28. Qureshi AA, Myckatyn TM, Tenenbaum MM. Mastopexy and mastopexy- augmentation. Aesthet
Surg J. 2018;38(4):374-84.
29. Ismail KT, Ismail MT, Ismail TA, Ismail AT. Toth BA. Triple-Plane Augmentation Mastopexy.
Plast Reconstr Surg Glob Open. 2019;7(8):e2344.
30. Migliori F. ‘‘Upside-down’’ augmentation mastopexy. Aesthetic Plast Surg. 2011;35(4):593-600.
31. Maclin II MM, Deigni OA, Bengtson BP. The Laminated Nature of the Pectoralis Major
Muscle and the Redefinition of the Inframammary Fold: Clinical Implications in Aesthetic
and Reconstructive Breast Surgery. Clin Plast Surg. 2015;42(4):465-79.
32. Madsen RJ Jr, Chim J. Variance in the origin of the pectoralis major muscle: implications
for the implant-based breast reconstruction. Ann Plast Surg. 2015;74(1):111-3.
33. Doshier LJ, Eagan SL, Shock LA, Henry SL, Colbert SH, Puckett CL. The Subtleties of
Success in Simultaneous Augmentation-Mastopexy. Plast Reconstr Surg. 2016;138(3):585-92.
34. Camargo VJ. Mamoplastia secundária com ressecção em monobloco e neoposicionamento
do implante no espaço retropeitoral parcial. Rev Bras Cir Plást. 2019;34(3):315-23.
35. Forcada EM, Fernandez MC, Aso JV, Iglesias IP. Augmentation mastopexy: Maximal reduction
and stable implant coverage using four flaps. Aesth Plast Surg. 2014;38(4):711-7.
36. Tessone A, Millet E, Weissman O, Stavrou D, Nardini G, Liran A, Winkler E. Evading
a surgical pitfall: mastopexy--augmentation made simple. Aesthet Plast Surg. 2011;35(6):1073-8.
37. Hubbard TJ. Vertical Augmentation Mastopexy with Implant Isolation and Tension Management.
Plast Reconstr Surg Glob Open. 2019;7(6):e2226.
1. Private practice, Curitiba, PR, Brazil.
Corresponding author: Luiz Roberto Reis Araujo, Alameda Presidente Taunay, 1820, Merces, Curitiba, PR, Brazil, Zip Code 80430-042,
E-mail: drluiz@drluizaraujo.com.br
Article received: March 16, 2021.
Article accepted: December 13, 2021.
Conflicts of interest: none.